Levy Alan J - Jan 26, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
Director
Signature
By: Donna Spinola For: Levy, Alan J
Stock symbol
ISRG
Transactions as of
Jan 26, 2024
Transactions value $
-$554,827
Form type
4
Date filed
1/29/2024, 05:28 PM
Previous filing
Nov 15, 2023
Next filing
Apr 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $11.1K +72 +0.28% $154.24 25.4K Jan 26, 2024 Direct F1
transaction ISRG Common Stock Sale -$26.7K -72 -0.28% $370.20 25.3K Jan 26, 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $174K +1.93K +7.61% $90.49 27.2K Jan 26, 2024 Direct F1
transaction ISRG Common Stock Sale -$714K -1.93K -7.08% $370.20 25.3K Jan 26, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.93K -100% $0.00 0 Jan 26, 2024 Common Stock 1.93K $90.49 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -72 -2.41% $0.00 2.92K Jan 26, 2024 Common Stock 72 $154.24 Direct F1, F3

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 8, 2024.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.90 to $371.65 as follows: 900 shares sold at $368.90 to $369.78; 600 shares sold at $370.04 to $370.71; and 500 shares sold at $371.60 to $371.65. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.